Keyword search

Filter results by

Search Help
Currently selected filters that can be removed

Keyword(s)

Type

1 facets displayed. 0 facets selected.

Year of publication

2 facets displayed. 0 facets selected.

Geography

1 facets displayed. 0 facets selected.

Survey or statistical program

1 facets displayed. 1 facets selected.
Sort Help
entries

Results

All (2)

All (2) ((2 results))

  • Articles and reports: 88-003-X20020016152
    Geography: Canada
    Description:

    The Biotechnology Use & Development Survey-1999 provides insights into the transition from R&D to the commercial use of a technology in products and processes. Improvement in product quality is reported as the number one benefit derived from using biotechnologies. This article explores some of the characteristics of the firms that use biotechnologies addressing the questions: "Why use biotechnology?" and "Why not use biotechnology?"

    Release date: 2002-02-15

  • Articles and reports: 88-003-X20000035772
    Geography: Canada
    Description:

    Technological change and innovations depend greatly on R&D activities and investments. R&D is concentrated around the "core firms" that are responsible for 87% of expenditures. Biotechnology R&D performers accounted for $904 million of R&D expenditure. Biotechnology R&D is concentrated in large firms with 75% of R&D occuring in firms with 100 or more employees. Almost 77% of funding sources for R&D in biotechnology came from the private sector and 21% from foreign sources.

    Release date: 2000-10-06
Data (0)

Data (0) (0 results)

No content available at this time.

Analysis (2)

Analysis (2) ((2 results))

  • Articles and reports: 88-003-X20020016152
    Geography: Canada
    Description:

    The Biotechnology Use & Development Survey-1999 provides insights into the transition from R&D to the commercial use of a technology in products and processes. Improvement in product quality is reported as the number one benefit derived from using biotechnologies. This article explores some of the characteristics of the firms that use biotechnologies addressing the questions: "Why use biotechnology?" and "Why not use biotechnology?"

    Release date: 2002-02-15

  • Articles and reports: 88-003-X20000035772
    Geography: Canada
    Description:

    Technological change and innovations depend greatly on R&D activities and investments. R&D is concentrated around the "core firms" that are responsible for 87% of expenditures. Biotechnology R&D performers accounted for $904 million of R&D expenditure. Biotechnology R&D is concentrated in large firms with 75% of R&D occuring in firms with 100 or more employees. Almost 77% of funding sources for R&D in biotechnology came from the private sector and 21% from foreign sources.

    Release date: 2000-10-06
Reference (0)

Reference (0) (0 results)

No content available at this time.

Date modified: